BIOABioAge Labs, Inc.
$6.35+30% 1Y
$6.35
$4.9452 weeks$24.29
Is the price fair?
What BIOA's price assumes
BioAge Labs, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 97.1× revenue.
97.1
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.68
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 66.3
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 2.68
- EV / EBIToperating margin −1026%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 66.3
- Market capitalisation
- $1.01B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Stocks with no debt
Drug Manufacturers, Specialty & Generic
The closest names by size in the same industry